Does TNF-α enhance cystogenesis in ADPKD?

Nephrology Dialysis Transplantation

Volumn 23, Issue 12, 2008, Pages 3773-3775

  Pirson, Yves ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Autosomal dominant polycystic kidney disease; Autosomal recessive polycystic kidney disease; Ethanercept; FIP 2; TNF

Indexed keywords

CYCLIC AMP; POLYCYSTIN 1; POLYCYSTIN 2; TUMOR NECROSIS FACTOR ALPHA;

GENE; GENE MUTATION; HUMAN; IMMUNOPATHOGENESIS; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PKD1 GENE; PKD2 GENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; MICE; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR TFIIIA; TRPP CATION CHANNELS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56749098337     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn533     Document Type: Note

References (24)

1. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301
2. Gonzalez-Perrett S, Kim K, Ibarra C et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci USA 2001; 98: 1182-1187
3. Chang MY, Ong AC. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment. Nephron Physiol 2008; 108: 1-7
4. Ahrabi AK, Terryn S, Valenti G et al. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice. J Am Soc Nephrol 2007; 18: 1740-1753
5. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet 2004; 13: 3069-3077
6. Chang MY, Parker E, Ibrahim S et al. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol Dial Transplant 2006; 21: 2078-2084
7. Persu A, Duyme M, Pirson Y et al. Comparison between siblings and twins supports a role for modifier genes in ADPKD. Kidney Int 2004; 66: 2132-2136
8. Li X, Magenheimer BS, Xia S et al. A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med 2008; Aug; 14(8): 863-8. Epub 2008 Jun 15
9. Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 2003; 14: 185-191
10. Vielhauer V, Mayadas TN. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol 2007; 27: 286-308
11. Gardner KD Jr, Burnside JS, Elzinga LW et al. Cytokines in fluids from polycystic kidneys. Kidney Int 1991; 39: 718-724
12. Nakamura T, Ebihara I, Fukui M et al. Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice. J Am Soc Nephrol 1993; 4: 1064-1072
13. Dell KM, Nemo R, Sweeney WE Jr et al. A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease. Kidney Int 2001; 60: 1240-1248
14. Li Y, Kang J, Horwitz MS. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 1998; 18: 1601-1610
15. Hattula K, Peranen J. FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr Biol 2000; 10: 1603-1606
16. Lindsay AJ, McCaffrey MW. Rab11-FIP2 functions in transferrin recycling and associates with endosomal membranes via its COOH-terminal domain. J Biol Chem 2002; 277: 27193-27199
17. Ducharme NA, Hales CM, Lapierre LA et al. MARK2/EMK1/Par-1Balpha phosphorylation of Rab11-family interacting protein 2 is necessary for the timely establishment of polarity in Madin-Darby canine kidney cells. Mol Biol Cell 2006; 17: 3625-3637
18. Lee DF, Kuo HP, Chen CT et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007; 130: 440-455
19. Shillingford JM, Murcia NS, Larson CH et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 2006; 103: 5466-5471
20. Gabow PA, Johnson AM, Kaehny WD et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992; 41: 1311-1319
21. Werder AA, Amos MA, Nielsen AH et al. Comparative effects of germfree and ambient environments on the development of cystic kidney disease in CFWwd mice. J Lab Clin Med 1984; 103: 399-407
22. de Heer E, Peters DJ. Innate immunity as a driving force in renal disease. Kidney Int 2008; 73: 7-8
23. Mrug M, Zhou J, Woo Y et al. Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int 2008; 73: 63-76
24. Stokes MB, Foster K, Markowitz GS et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 2005; 20: 1400-1406